SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-309200
Filing Date
2022-12-20
Accepted
2022-12-20 16:54:07
Documents
12
Period of Report
2022-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d420010d8k.htm   iXBRL 8-K 30558
  Complete submission text file 0001193125-22-309200.txt   157269

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vtyx-20221220.xsd EX-101.SCH 2845
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtyx-20221220_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtyx-20221220_pre.xml EX-101.PRE 11704
6 EXTRACTED XBRL INSTANCE DOCUMENT d420010d8k_htm.xml XML 3471
Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40928 | Film No.: 221475469
SIC: 2834 Pharmaceutical Preparations